Dimethylformamide → N1-(4-Difluoromethoxybenzoyl)-N2-[1-(4-pyridyl)piperidin-4-ylmethoxycarbonyl]-1,2-benzenediamine Hydrochloride

HRID 427669

反応式

HRID 427669 の反応式
N1C=CC([N:7]2[CH2:12][CH2:11][CH:10]([CH2:13][O:14][C:15]([NH:17][C:18]3[C:19]([NH2:24])=[CH:20][CH:21]=[CH:22][CH:23]=3)=[O:16])[CH2:9][CH2:8]2)=CC=1.[F:25][CH:26]([F:37])[O:27][C:28]1[CH:36]=[CH:35][C:31]([C:32]([OH:34])=O)=[CH:30][CH:29]=1.[ClH:38].CN(C)[CH2:41][CH2:42][CH2:43][N:44]=[C:45]=NCC.[CH3:50]N(C=O)C>>[ClH:38].[F:37][CH:26]([F:25])[O:27][C:28]1[CH:29]=[CH:30][C:31]([C:32]([NH:24][C:19]2[C:18]([NH:17][C:15]([O:14][CH:13]([CH:10]3[CH2:9][CH2:8][NH:7][CH2:12][CH2:11]3)[C:41]3[CH:42]=[CH:43][N:44]=[CH:45][CH:50]=3)=[O:16])=[CH:23][CH:22]=[CH:21][CH:20]=2)=[O:34])=[CH:35][CH:36]=1

参加物

5

実験手順

To a solution of N1-[1-(4-pyridyl)piperidin-4-yl-methoxycarbonyl]-1,2-benzenediamine (0.2 g, 0.6 mmol) and 4-difluoromethoxybenzoic acid (0.23 g, 1.2 mmol) in DMF (10 mL) was added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.24 g, 1.2 mmol). After stirring overnight, the solvent was removed in vacuo and the residue was partitioned between ethyl acetate (300 mL) and 1 N NaOH (150 ml). The layers were separated and the organic phase was washed with brine, dried with MgSO4, filtered and concentrated in vacuo. The residue was purified by RPHPLC method A and the fractions containing pure product were combined and lypholized to give 123 mg (38%) of the title product as a white solid.

後処理

  1. customthe solvent was removed in vacuo
  2. customthe residue was partitioned between ethyl acetate (300 mL) and 1 N NaOH (150 ml)
  3. customThe layers were separated
  4. washthe organic phase was washed with brine
  5. dry with materialdried with MgSO4
  6. filtrationfiltered
  7. concentrationconcentrated in vacuo
  8. customThe residue was purified by RPHPLC method A
  9. additionthe fractions containing pure product

出典と根拠

ORDレコード
ord-ede4f5886f7c4bdca988094cfef1c0e2
出典データセット
uspto-grants-2001_11
特許番号
US06313122B1

関連ノート

読み込み中…